• Home >>
  • Pharmaceuticals and Healthcare

Covid-19 Impact on Global Antiviral Oral Liquid Market Size, Status and Forecast 2020-2026

  • ID : 1251526
  • Date : 22 June 2020
  • Region : Global
  • Pages :129

CHOOSE LICENCE TYPE

Antiviral Oral Liquid market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antiviral Oral Liquid market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Antiviral Oral Liquid market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future. This report also analyzes the impact of Coronavirus COVID-19 on the Antiviral Oral Liquid industry. The key players covered in this study Pfizer Roche Novartis Merck GlaxoSmithKline Johnson & Johnson AbbVie Sanofi Bristol-Myers Squibb AstraZeneca Eli Lilly Novo Nordisk Amgen Gilead Sciences CSL Takeda Pharmaceuticals Bayer Celgene Merck KGaA Allergan Market segment by Type, the product can be split into Syrup Oral suspension Oral solution Oral drop Oral emulsion Mixture Market segment by Application, split into Adults Children Market segment by Regions/Countries, this report covers North America Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Antiviral Oral Liquid status, future forecast, growth opportunity, key market and key players. To present the Antiviral Oral Liquid development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by type, market and key regions. In this study, the years considered to estimate the market size of Antiviral Oral Liquid are as follows: History Year: 2015-2019 Base Year: 2019 Estimated Year: 2020 Forecast Year 2020 to 2026 For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Antiviral Oral Liquid Revenue 1.4 Covid-19 Implications on Market by Type 1.4.1 Global Antiviral Oral Liquid Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Syrup 1.4.3 Oral suspension 1.4.4 Oral solution 1.4.5 Oral drop 1.4.6 Oral emulsion 1.4.7 Mixture 1.5 Market by Application 1.5.1 Global Antiviral Oral Liquid Market Share by Application: 2020 VS 2026 1.5.2 Adults 1.5.3 Children 1.6 Coronavirus Disease 2019 (Covid-19): Antiviral Oral Liquid Industry Impact 1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 1.6.2 Covid-19 Impact: Commodity Prices Indices 1.6.3 Covid-19 Impact: Global Major Government Policy 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends 2.1 Covid-19 Implications on Global Antiviral Oral Liquid Market Perspective (2015-2026) 2.2 Covid-19 Implications on Global Antiviral Oral Liquid Growth Trends by Regions 2.2.1 Antiviral Oral Liquid Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Antiviral Oral Liquid Historic Market Share by Regions (2015-2020) 2.2.3 Antiviral Oral Liquid Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Antiviral Oral Liquid Market Growth Strategy 2.3.6 Primary Interviews with Key Antiviral Oral Liquid Players (Opinion Leaders) 3 Covid-19 Implications on Competition Landscape by Key Players 3.1 Global Top Antiviral Oral Liquid Players by Market Size 3.1.1 Global Top Antiviral Oral Liquid Players by Revenue (2015-2020) 3.1.2 Global Antiviral Oral Liquid Revenue Market Share by Players (2015-2020) 3.1.3 Global Antiviral Oral Liquid Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Antiviral Oral Liquid Market Concentration Ratio 3.2.1 Global Antiviral Oral Liquid Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Antiviral Oral Liquid Revenue in 2019 3.3 Antiviral Oral Liquid Key Players Head office and Area Served 3.4 Key Players Antiviral Oral Liquid Product Solution and Service 3.5 Date of Enter into Antiviral Oral Liquid Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Covid-19 Implications on Market Size by Type (2015-2026) 4.1 Global Antiviral Oral Liquid Historic Market Size by Type (2015-2020) 4.2 Global Antiviral Oral Liquid Forecasted Market Size by Type (2021-2026) 5 Covid-19 Implications on Market Size by Application (2015-2026) 5.1 Global Antiviral Oral Liquid Market Size by Application (2015-2020) 5.2 Global Antiviral Oral Liquid Forecasted Market Size by Application (2021-2026) 6 North America Impact of COVID-19 6.1 North America Antiviral Oral Liquid Market Size (2015-2020) 6.2 Antiviral Oral Liquid Key Players in North America (2019-2020) 6.3 North America Antiviral Oral Liquid Market Size by Type (2015-2020) 6.4 North America Antiviral Oral Liquid Market Size by Application (2015-2020) 7 Europe Impact of COVID-19 7.1 Europe Antiviral Oral Liquid Market Size (2015-2020) 7.2 Antiviral Oral Liquid Key Players in Europe (2019-2020) 7.3 Europe Antiviral Oral Liquid Market Size by Type (2015-2020) 7.4 Europe Antiviral Oral Liquid Market Size by Application (2015-2020) 8 China Impact of COVID-19 8.1 China Antiviral Oral Liquid Market Size (2015-2020) 8.2 Antiviral Oral Liquid Key Players in China (2019-2020) 8.3 China Antiviral Oral Liquid Market Size by Type (2015-2020) 8.4 China Antiviral Oral Liquid Market Size by Application (2015-2020) 9 Japan Impact of COVID-19 9.1 Japan Antiviral Oral Liquid Market Size (2015-2020) 9.2 Antiviral Oral Liquid Key Players in Japan (2019-2020) 9.3 Japan Antiviral Oral Liquid Market Size by Type (2015-2020) 9.4 Japan Antiviral Oral Liquid Market Size by Application (2015-2020) 10 Southeast Asia Impact of COVID-19 10.1 Southeast Asia Antiviral Oral Liquid Market Size (2015-2020) 10.2 Antiviral Oral Liquid Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Antiviral Oral Liquid Market Size by Type (2015-2020) 10.4 Southeast Asia Antiviral Oral Liquid Market Size by Application (2015-2020) 11 India Impact of COVID-19 11.1 India Antiviral Oral Liquid Market Size (2015-2020) 11.2 Antiviral Oral Liquid Key Players in India (2019-2020) 11.3 India Antiviral Oral Liquid Market Size by Type (2015-2020) 11.4 India Antiviral Oral Liquid Market Size by Application (2015-2020) 12 Central & South America Impact of COVID-19 12.1 Central & South America Antiviral Oral Liquid Market Size (2015-2020) 12.2 Antiviral Oral Liquid Key Players in Central & South America (2019-2020) 12.3 Central & South America Antiviral Oral Liquid Market Size by Type (2015-2020) 12.4 Central & South America Antiviral Oral Liquid Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Pfizer 13.1.1 Pfizer Company Details 13.1.2 Pfizer Business Overview and Its Total Revenue 13.1.3 Pfizer Antiviral Oral Liquid Introduction 13.1.4 Pfizer Revenue in Antiviral Oral Liquid Business (2015-2020)) 13.1.5 Pfizer Recent Development and Reaction to COVID-19 13.2 Roche 13.2.1 Roche Company Details 13.2.2 Roche Business Overview and Its Total Revenue 13.2.3 Roche Antiviral Oral Liquid Introduction 13.2.4 Roche Revenue in Antiviral Oral Liquid Business (2015-2020) 13.2.5 Roche Recent Development and Reaction to COVID-19 13.3 Novartis 13.3.1 Novartis Company Details 13.3.2 Novartis Business Overview and Its Total Revenue 13.3.3 Novartis Antiviral Oral Liquid Introduction 13.3.4 Novartis Revenue in Antiviral Oral Liquid Business (2015-2020) 13.3.5 Novartis Recent Development and Reaction to COVID-19 13.4 Merck 13.4.1 Merck Company Details 13.4.2 Merck Business Overview and Its Total Revenue 13.4.3 Merck Antiviral Oral Liquid Introduction 13.4.4 Merck Revenue in Antiviral Oral Liquid Business (2015-2020) 13.4.5 Merck Recent Development and Reaction to COVID-19 13.5 GlaxoSmithKline 13.5.1 GlaxoSmithKline Company Details 13.5.2 GlaxoSmithKline Business Overview and Its Total Revenue 13.5.3 GlaxoSmithKline Antiviral Oral Liquid Introduction 13.5.4 GlaxoSmithKline Revenue in Antiviral Oral Liquid Business (2015-2020) 13.5.5 GlaxoSmithKline Recent Development and Reaction to COVID-19 13.6 Johnson & Johnson 13.6.1 Johnson & Johnson Company Details 13.6.2 Johnson & Johnson Business Overview and Its Total Revenue 13.6.3 Johnson & Johnson Antiviral Oral Liquid Introduction 13.6.4 Johnson & Johnson Revenue in Antiviral Oral Liquid Business (2015-2020) 13.6.5 Johnson & Johnson Recent Development and Reaction to COVID-19 13.7 AbbVie 13.7.1 AbbVie Company Details 13.7.2 AbbVie Business Overview and Its Total Revenue 13.7.3 AbbVie Antiviral Oral Liquid Introduction 13.7.4 AbbVie Revenue in Antiviral Oral Liquid Business (2015-2020) 13.7.5 AbbVie Recent Development and Reaction to COVID-19 13.8 Sanofi 13.8.1 Sanofi Company Details 13.8.2 Sanofi Business Overview and Its Total Revenue 13.8.3 Sanofi Antiviral Oral Liquid Introduction 13.8.4 Sanofi Revenue in Antiviral Oral Liquid Business (2015-2020) 13.8.5 Sanofi Recent Development and Reaction to COVID-19 13.9 Bristol-Myers Squibb 13.9.1 Bristol-Myers Squibb Company Details 13.9.2 Bristol-Myers Squibb Business Overview and Its Total Revenue 13.9.3 Bristol-Myers Squibb Antiviral Oral Liquid Introduction 13.9.4 Bristol-Myers Squibb Revenue in Antiviral Oral Liquid Business (2015-2020) 13.9.5 Bristol-Myers Squibb Recent Development and Reaction to COVID-19 13.10 AstraZeneca 13.10.1 AstraZeneca Company Details 13.10.2 AstraZeneca Business Overview and Its Total Revenue 13.10.3 AstraZeneca Antiviral Oral Liquid Introduction 13.10.4 AstraZeneca Revenue in Antiviral Oral Liquid Business (2015-2020) 13.10.5 AstraZeneca Recent Development and Reaction to COVID-19 13.11 Eli Lilly 10.11.1 Eli Lilly Company Details 10.11.2 Eli Lilly Business Overview and Its Total Revenue 10.11.3 Eli Lilly Antiviral Oral Liquid Introduction 10.11.4 Eli Lilly Revenue in Antiviral Oral Liquid Business (2015-2020) 10.11.5 Eli Lilly Recent Development and Reaction to COVID-19 13.12 Novo Nordisk 10.12.1 Novo Nordisk Company Details 10.12.2 Novo Nordisk Business Overview and Its Total Revenue 10.12.3 Novo Nordisk Antiviral Oral Liquid Introduction 10.12.4 Novo Nordisk Revenue in Antiviral Oral Liquid Business (2015-2020) 10.12.5 Novo Nordisk Recent Development and Reaction to COVID-19 13.13 Amgen 10.13.1 Amgen Company Details 10.13.2 Amgen Business Overview and Its Total Revenue 10.13.3 Amgen Antiviral Oral Liquid Introduction 10.13.4 Amgen Revenue in Antiviral Oral Liquid Business (2015-2020) 10.13.5 Amgen Recent Development and Reaction to COVID-19 13.14 Gilead Sciences 10.14.1 Gilead Sciences Company Details 10.14.2 Gilead Sciences Business Overview and Its Total Revenue 10.14.3 Gilead Sciences Antiviral Oral Liquid Introduction 10.14.4 Gilead Sciences Revenue in Antiviral Oral Liquid Business (2015-2020) 10.14.5 Gilead Sciences Recent Development and Reaction to COVID-19 13.15 CSL 10.15.1 CSL Company Details 10.15.2 CSL Business Overview and Its Total Revenue 10.15.3 CSL Antiviral Oral Liquid Introduction 10.15.4 CSL Revenue in Antiviral Oral Liquid Business (2015-2020) 10.15.5 CSL Recent Development and Reaction to COVID-19 13.16 Takeda Pharmaceuticals 10.16.1 Takeda Pharmaceuticals Company Details 10.16.2 Takeda Pharmaceuticals Business Overview and Its Total Revenue 10.16.3 Takeda Pharmaceuticals Antiviral Oral Liquid Introduction 10.16.4 Takeda Pharmaceuticals Revenue in Antiviral Oral Liquid Business (2015-2020) 10.16.5 Takeda Pharmaceuticals Recent Development and Reaction to COVID-19 13.17 Bayer 10.17.1 Bayer Company Details 10.17.2 Bayer Business Overview and Its Total Revenue 10.17.3 Bayer Antiviral Oral Liquid Introduction 10.17.4 Bayer Revenue in Antiviral Oral Liquid Business (2015-2020) 10.17.5 Bayer Recent Development and Reaction to COVID-19 13.18 Celgene 10.18.1 Celgene Company Details 10.18.2 Celgene Business Overview and Its Total Revenue 10.18.3 Celgene Antiviral Oral Liquid Introduction 10.18.4 Celgene Revenue in Antiviral Oral Liquid Business (2015-2020) 10.18.5 Celgene Recent Development and Reaction to COVID-19 13.19 Merck KGaA 10.19.1 Merck KGaA Company Details 10.19.2 Merck KGaA Business Overview and Its Total Revenue 10.19.3 Merck KGaA Antiviral Oral Liquid Introduction 10.19.4 Merck KGaA Revenue in Antiviral Oral Liquid Business (2015-2020) 10.19.5 Merck KGaA Recent Development and Reaction to COVID-19 13.20 Allergan 10.20.1 Allergan Company Details 10.20.2 Allergan Business Overview and Its Total Revenue 10.20.3 Allergan Antiviral Oral Liquid Introduction 10.20.4 Allergan Revenue in Antiviral Oral Liquid Business (2015-2020) 10.20.5 Allergan Recent Development and Reaction to COVID-19 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Antiviral Oral Liquid Key Market Segments Table 2. Key Players Covered: Ranking by Antiviral Oral Liquid Revenue Table 3. Ranking of Global Top Antiviral Oral Liquid Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Antiviral Oral Liquid Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Syrup Table 6. Key Players of Oral suspension Table 7. Key Players of Oral solution Table 8. Key Players of Oral drop Table 9. Key Players of Oral emulsion Table 10. Key Players of Mixture Table 11. COVID-19 Impact Global Market: (Four Antiviral Oral Liquid Market Size Forecast Scenarios) Table 12. Opportunities and Trends for Antiviral Oral Liquid Players in the COVID-19 Landscape Table 13. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 14. Key Regions/Countries Measures against Covid-19 Impact Table 15. Proposal for Antiviral Oral Liquid Players to Combat Covid-19 Impact Table 16. Global Antiviral Oral Liquid Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 17. Global Antiviral Oral Liquid Market Size by Regions (US$ Million): 2020 VS 2026 Table 18. Global Antiviral Oral Liquid Market Size by Regions (2015-2020) (US$ Million) Table 19. Global Antiviral Oral Liquid Market Share by Regions (2015-2020) Table 20. Global Antiviral Oral Liquid Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 21. Global Antiviral Oral Liquid Market Share by Regions (2021-2026) Table 22. Market Top Trends Table 23. Key Drivers: Impact Analysis Table 24. Key Challenges Table 25. Antiviral Oral Liquid Market Growth Strategy Table 26. Main Points Interviewed from Key Antiviral Oral Liquid Players Table 27. Global Antiviral Oral Liquid Revenue by Players (2015-2020) (Million US$) Table 28. Global Antiviral Oral Liquid Market Share by Players (2015-2020) Table 29. Global Top Antiviral Oral Liquid Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiviral Oral Liquid as of 2019) Table 30. Global Antiviral Oral Liquid by Players Market Concentration Ratio (CR5 and HHI) Table 31. Key Players Headquarters and Area Served Table 32. Key Players Antiviral Oral Liquid Product Solution and Service Table 33. Date of Enter into Antiviral Oral Liquid Market Table 34. Mergers & Acquisitions, Expansion Plans Table 35. Global Antiviral Oral Liquid Market Size by Type (2015-2020) (Million US$) Table 36. Global Antiviral Oral Liquid Market Size Share by Type (2015-2020) Table 37. Global Antiviral Oral Liquid Revenue Market Share by Type (2021-2026) Table 38. Global Antiviral Oral Liquid Market Size Share by Application (2015-2020) Table 39. Global Antiviral Oral Liquid Market Size by Application (2015-2020) (Million US$) Table 40. Global Antiviral Oral Liquid Market Size Share by Application (2021-2026) Table 41. North America Key Players Antiviral Oral Liquid Revenue (2019-2020) (Million US$) Table 42. North America Key Players Antiviral Oral Liquid Market Share (2019-2020) Table 43. North America Antiviral Oral Liquid Market Size by Type (2015-2020) (Million US$) Table 44. North America Antiviral Oral Liquid Market Share by Type (2015-2020) Table 45. North America Antiviral Oral Liquid Market Size by Application (2015-2020) (Million US$) Table 46. North America Antiviral Oral Liquid Market Share by Application (2015-2020) Table 47. Europe Key Players Antiviral Oral Liquid Revenue (2019-2020) (Million US$) Table 48. Europe Key Players Antiviral Oral Liquid Market Share (2019-2020) Table 49. Europe Antiviral Oral Liquid Market Size by Type (2015-2020) (Million US$) Table 50. Europe Antiviral Oral Liquid Market Share by Type (2015-2020) Table 51. Europe Antiviral Oral Liquid Market Size by Application (2015-2020) (Million US$) Table 52. Europe Antiviral Oral Liquid Market Share by Application (2015-2020) Table 53. China Key Players Antiviral Oral Liquid Revenue (2019-2020) (Million US$) Table 54. China Key Players Antiviral Oral Liquid Market Share (2019-2020) Table 55. China Antiviral Oral Liquid Market Size by Type (2015-2020) (Million US$) Table 56. China Antiviral Oral Liquid Market Share by Type (2015-2020) Table 57. China Antiviral Oral Liquid Market Size by Application (2015-2020) (Million US$) Table 58. China Antiviral Oral Liquid Market Share by Application (2015-2020) Table 59. Japan Key Players Antiviral Oral Liquid Revenue (2019-2020) (Million US$) Table 60. Japan Key Players Antiviral Oral Liquid Market Share (2019-2020) Table 61. Japan Antiviral Oral Liquid Market Size by Type (2015-2020) (Million US$) Table 62. Japan Antiviral Oral Liquid Market Share by Type (2015-2020) Table 63. Japan Antiviral Oral Liquid Market Size by Application (2015-2020) (Million US$) Table 64. Japan Antiviral Oral Liquid Market Share by Application (2015-2020) Table 65. Southeast Asia Key Players Antiviral Oral Liquid Revenue (2019-2020) (Million US$) Table 66. Southeast Asia Key Players Antiviral Oral Liquid Market Share (2019-2020) Table 67. Southeast Asia Antiviral Oral Liquid Market Size by Type (2015-2020) (Million US$) Table 68. Southeast Asia Antiviral Oral Liquid Market Share by Type (2015-2020) Table 69. Southeast Asia Antiviral Oral Liquid Market Size by Application (2015-2020) (Million US$) Table 70. Southeast Asia Antiviral Oral Liquid Market Share by Application (2015-2020) Table 71. India Key Players Antiviral Oral Liquid Revenue (2019-2020) (Million US$) Table 72. India Key Players Antiviral Oral Liquid Market Share (2019-2020) Table 73. India Antiviral Oral Liquid Market Size by Type (2015-2020) (Million US$) Table 74. India Antiviral Oral Liquid Market Share by Type (2015-2020) Table 75. India Antiviral Oral Liquid Market Size by Application (2015-2020) (Million US$) Table 76. India Antiviral Oral Liquid Market Share by Application (2015-2020) Table 77. Central & South America Key Players Antiviral Oral Liquid Revenue (2019-2020) (Million US$) Table 78. Central & South America Key Players Antiviral Oral Liquid Market Share (2019-2020) Table 79. Central & South America Antiviral Oral Liquid Market Size by Type (2015-2020) (Million US$) Table 80. Central & South America Antiviral Oral Liquid Market Share by Type (2015-2020) Table 81. Central & South America Antiviral Oral Liquid Market Size by Application (2015-2020) (Million US$) Table 82. Central & South America Antiviral Oral Liquid Market Share by Application (2015-2020) Table 83. Pfizer Company Details Table 84. Pfizer Business Overview Table 85. Pfizer Product Table 86. Pfizer Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$) Table 87. Pfizer Recent Development Table 88. Roche Company Details Table 89. Roche Business Overview Table 90. Roche Product Table 91. Roche Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$) Table 92. Roche Recent Development Table 93. Novartis Company Details Table 94. Novartis Business Overview Table 95. Novartis Product Table 96. Novartis Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$) Table 97. Novartis Recent Development Table 98. Merck Company Details Table 99. Merck Business Overview Table 100. Merck Product Table 101. Merck Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$) Table 102. Merck Recent Development Table 103. GlaxoSmithKline Company Details Table 104. GlaxoSmithKline Business Overview Table 105. GlaxoSmithKline Product Table 106. GlaxoSmithKline Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$) Table 107. GlaxoSmithKline Recent Development Table 108. Johnson & Johnson Company Details Table 109. Johnson & Johnson Business Overview Table 110. Johnson & Johnson Product Table 111. Johnson & Johnson Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$) Table 112. Johnson & Johnson Recent Development Table 113. AbbVie Company Details Table 114. AbbVie Business Overview Table 115. AbbVie Product Table 116. AbbVie Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$) Table 117. AbbVie Recent Development Table 118. Sanofi Business Overview Table 119. Sanofi Product Table 120. Sanofi Company Details Table 121. Sanofi Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$) Table 122. Sanofi Recent Development Table 123. Bristol-Myers Squibb Company Details Table 124. Bristol-Myers Squibb Business Overview Table 125. Bristol-Myers Squibb Product Table 126. Bristol-Myers Squibb Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$) Table 127. Bristol-Myers Squibb Recent Development Table 128. AstraZeneca Company Details Table 129. AstraZeneca Business Overview Table 130. AstraZeneca Product Table 131. AstraZeneca Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$) Table 132. AstraZeneca Recent Development Table 133. Eli Lilly Company Details Table 134. Eli Lilly Business Overview Table 135. Eli Lilly Product Table 136. Eli Lilly Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$) Table 137. Eli Lilly Recent Development Table 138. Novo Nordisk Company Details Table 139. Novo Nordisk Business Overview Table 140. Novo Nordisk Product Table 141. Novo Nordisk Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$) Table 142. Novo Nordisk Recent Development Table 143. Amgen Company Details Table 144. Amgen Business Overview Table 145. Amgen Product Table 146. Amgen Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$) Table 147. Amgen Recent Development Table 148. Gilead Sciences Company Details Table 149. Gilead Sciences Business Overview Table 150. Gilead Sciences Product Table 151. Gilead Sciences Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$) Table 152. Gilead Sciences Recent Development Table 153. CSL Company Details Table 154. CSL Business Overview Table 155. CSL Product Table 156. CSL Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$) Table 157. CSL Recent Development Table 158. Takeda Pharmaceuticals Company Details Table 159. Takeda Pharmaceuticals Business Overview Table 160. Takeda Pharmaceuticals Product Table 161. Takeda Pharmaceuticals Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$) Table 162. Takeda Pharmaceuticals Recent Development Table 163. Bayer Company Details Table 164. Bayer Business Overview Table 165. Bayer Product Table 166. Bayer Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$) Table 167. Bayer Recent Development Table 168. Celgene Company Details Table 169. Celgene Business Overview Table 170. Celgene Product Table 171. Celgene Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$) Table 172. Celgene Recent Development Table 173. Merck KGaA Company Details Table 174. Merck KGaA Business Overview Table 175. Merck KGaA Product Table 176. Merck KGaA Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$) Table 177. Merck KGaA Recent Development Table 178. Allergan Company Details Table 179. Allergan Business Overview Table 180. Allergan Product Table 181. Allergan Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$) Table 182. Allergan Recent Development Table 183. Research Programs/Design for This Report Table 184. Key Data Information from Secondary Sources Table 185. Key Data Information from Primary Sources List of Figures Figure 1. Global Antiviral Oral Liquid Market Share by Type: 2020 VS 2026 Figure 2. Syrup Features Figure 3. Oral suspension Features Figure 4. Oral solution Features Figure 5. Oral drop Features Figure 6. Oral emulsion Features Figure 7. Mixture Features Figure 8. Global Antiviral Oral Liquid Market Share by Application: 2020 VS 2026 Figure 9. Adults Case Studies Figure 10. Children Case Studies Figure 11. Antiviral Oral Liquid Report Years Considered Figure 12. Global Antiviral Oral Liquid Market Size YoY Growth 2015-2026 (US$ Million) Figure 13. Global Antiviral Oral Liquid Market Share by Regions: 2020 VS 2026 Figure 14. Global Antiviral Oral Liquid Market Share by Regions (2021-2026) Figure 15. Porter's Five Forces Analysis Figure 16. Global Antiviral Oral Liquid Market Share by Players in 2019 Figure 17. Global Top Antiviral Oral Liquid Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiviral Oral Liquid as of 2019 Figure 18. The Top 10 and 5 Players Market Share by Antiviral Oral Liquid Revenue in 2019 Figure 19. North America Antiviral Oral Liquid Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Europe Antiviral Oral Liquid Market Size YoY Growth (2015-2020) (Million US$) Figure 21. China Antiviral Oral Liquid Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Japan Antiviral Oral Liquid Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Southeast Asia Antiviral Oral Liquid Market Size YoY Growth (2015-2020) (Million US$) Figure 24. India Antiviral Oral Liquid Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Central & South America Antiviral Oral Liquid Market Size YoY Growth (2015-2020) (Million US$) Figure 26. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Pfizer Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020) Figure 28. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Roche Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020) Figure 30. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Novartis Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020) Figure 32. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Merck Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020) Figure 34. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. GlaxoSmithKline Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020) Figure 36. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Johnson & Johnson Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020) Figure 38. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. AbbVie Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020) Figure 40. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. Sanofi Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020) Figure 42. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018 Figure 43. Bristol-Myers Squibb Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020) Figure 44. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018 Figure 45. AstraZeneca Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020) Figure 46. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018 Figure 47. Eli Lilly Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020) Figure 48. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018 Figure 49. Novo Nordisk Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020) Figure 50. Amgen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 51. Amgen Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020) Figure 52. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018 Figure 53. Gilead Sciences Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020) Figure 54. CSL Total Revenue (US$ Million): 2019 Compared with 2018 Figure 55. CSL Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020) Figure 56. Takeda Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 57. Takeda Pharmaceuticals Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020) Figure 58. Bayer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 59. Bayer Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020) Figure 60. Celgene Total Revenue (US$ Million): 2019 Compared with 2018 Figure 61. Celgene Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020) Figure 62. Merck KGaA Total Revenue (US$ Million): 2019 Compared with 2018 Figure 63. Merck KGaA Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020) Figure 64. Allergan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 65. Allergan Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

CHOOSE LICENCE TYPE

TESTIMONIALS

What amazed me most was the professionalism and client satisfaction provided by Garner Insights. Their responses were quick and actioned on immediately.

Sr. Manager
A UK based manufacturing firm

I would like to thank the team at Garner Insights, you guys made my job so easier with your spoon fed service and quality market study.

President
At a US based consulting firm

The team of Garner Insights solved my queries in a timely fashion and gracefully. I have purchased reports from them a few times now and they never cease to impress with their highly intellectual team.

Marketing Manager
At a Fortune 100 pharmaceutical firm

I had some issues with the payment gateway and almost the immediate second I get a call from one of the enthusiastic sales member who guided me throughout the process and also reassured me of the next steps.

A Consultant
At a German based retail firm

The quality of data encompassed in the report was very useful for me in my marketing strategy needs

Director of Marketing
At a US based Manufacturing firm

What's Included

  • Market Size
  • Market Share
  • Market Segmentation
  • Market Forecast
  • Regional Segment Analysis
  • Compound Annual Growth Rate
  • Company & Brand Details
  • Market Revenue and Growth Opportunities
  • Safe and Secure

FAQ's

By product type
By End User/Applications
By Technology
By Leading Industry Players
By Region
We will send you an email with login credentials to access the report. You will also be able to download the pdf.
The study on the impact of COVID-19 on the global market is classified into different segments and analysed based on regions, including North America, Europe, Asia-Pacific, and Rest of World.

To request a free sample copy of this report, please complete the form below.

OUR CLIENTS

product product product product product product

OR
CHOOSE LICENCE TYPE

Every Sample
Will Help to Understand

  • Report Structure and Outline
  • Detailed Table of Content (Including List of Tables and Figures)
  • Research Methodology

Check discount for this report, please complete the form below.

OUR CLIENTS

product product product product product product

OR
CHOOSE LICENCE TYPE

Every Sample
Will Help to Understand

  • Report Structure and Outline
  • Detailed Table of Content (Including List of Tables and Figures)
  • Research Methodology

OUR CLIENTS

product product product product product product

OR
CHOOSE LICENCE TYPE

Every Sample
Will Help to Understand

  • Report Structure and Outline
  • Detailed Table of Content (Including List of Tables and Figures)
  • Research Methodology